Crossing the Chasm for Digital Therapeutics (DTx) in Pharmaceuticals
care innovations
OCTOBER 15, 2021
And this is possible thanks to the unprecedented availability of data collected from the home, mobile endpoints, EMRs, trials and other social determinants. As we continue to see early adopters cross the DTx chasm, Frost & Sullivan project that DTx will become the new standard of care by 2025. Designing a Successful DTx Program.
Let's personalize your content